Production of a Platelet Aggregation Inhibitor, Salmosin, by High Cell Density Fermentation of Recombinant Escherichia coli |
Seo, Myung-Ji
(Department of Chemistry, Box H, Brown University)
Choi, Hak-Jong (Department of Microbiology and Immunology, Northwestern University) Chung, Kwang-Hoe (Deaprtment of Applied Bioscience, CHA University) Pyun, Yu-Ryang (Department of Biotechnology, Yonsei University) |
1 | Kang, I. C., K. H. Chung, S. J. Lee, Y. D. Yoon, H. M. Moon, and D. S. Kim. 1998. Purification and molecular cloning of a platelet aggregation inhibitor from the snake (Agkistrodon halys brevicaudus) venom. Thromb. Res. 91: 65-73. DOI ScienceOn |
2 | Kang, I. C., Y. D. Lee, and D. S. Kim. 1999. A novel disintegrin salmosin inhibits tumor angiogenesis. Cancer Res. 59: 3754-3760. |
3 | Kim, S. J., N. J. Kim, C. Shin, and C. W. Kim. 2008. Optimization of culture condition for the production of acid oxidase in a recombinant Escherichia coli. Biotechnol. Bioprocess Eng. 13: 144-149. DOI |
4 | Hong, S. Y., H. Lee, W. K. You, K. H. Chung, D. S. Kim, and K. Song. 2003. The snake venom disintegrin salmosin induces apoptosis by disassembly of focal adhesions in bovine capillary endothelial cells. Biochem. Biophys. Res. Commun. 302: 502-508. DOI ScienceOn |
5 | Hong, S. Y., Y. S. Koh, K. H. Chung, and D. S. Kim. 2002. Snake venom disintegrin, saxatilin, inhibits platelet aggregation, human umbilical vein endothelial cell proliferation, and smooth muscle cell migration. Thromb. Res. 105: 79-86. DOI ScienceOn |
6 | Huang, T. F., C. Z. Liu, C. H. Ouyang, and C. M. Teng. 1991. Halysin, an antiplatalet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist. Biochem. Pharmacol. 42: 1209-1219. DOI ScienceOn |
7 | Eiteman, M. A. and E. Altman. 2006. Overcoming acetate in Escherichia coli recombinant protein fermentations. Trends Biotechnol. 24: 530-536. DOI ScienceOn |
8 | Jeong, K. J. and M. Rani. 2011. High-level production of a single chain antibody against anthrax toxin in Escherichia coli by high cell density cultivation. Bioprocess Biosyst. Eng. 34: 811-817. DOI ScienceOn |
9 | Dasari, V. K. R., D. Are, V. R. Joginapally, L. N. Mangamoori, and K. S. B. R. Adibhatla. 2008. Optimization of the downstream process for high recovery of rhG-CSF from inclusion bodies expressed in Escherichia coli. Process Biochem. 43: 566-575. DOI ScienceOn |
10 | Dennis, M. S., W. J. Henzel, R. M. Pitti, M. T. Lipari, M. A. Napier, T. A. Deisher, S. Bunting, and R. A. Lazarus. 1990. Platelet glycoprotein IIb-IIIa protein antagonists from snake venoms: Evidence for a family of platelet-aggregation inhibitors. Proc. Natl. Acad. Sci. USA 87: 2471-2475. DOI ScienceOn |
11 | Packham, M. A. and J. F. Mustard. 1977. Clinical pharmacology of platelets. Blood 50: 555-573. |
12 | Gould, R. J., M. A. Polokoff, P. A. Friedman, T. F. Huang, J. C. Holt, J. J. Cook, and S. Niewiarowski. 1990. Disintegrins: A family of integrin inhibitory proteins from viper venoms. Proc. Soc. Exp. Biol. Med. 195: 168-171. |
13 | Bae, C. S., M. S. Hong, S. G. Chang, D. Y. Kim, and H. C. Shin. 1997. Optimization of fusion proinsulin production by high cell-density fermentation of recombinant E. coli. Biotechnol. Bioprocess Eng. 2: 27-32. DOI |
14 | Curtis-Fisk, J., R. M. Spencer, and D. P. Weliky. 2008. Isotopically labeled expression in E. coli, purification, and refolding of the full ectodomain of the influenza virus membrane fusion protein. Protein Expr. Purif. 61: 212-219. DOI ScienceOn |
15 | Savage, B., U. M. Marzec, B. H. Chao, L. A. Harker, J. M. Maraganore, and Z. M. Ruggeri. 1990. Binding of the snake venom-derived proteins applaggin and echistatin to the arginine-glycine- aspartic acid recognition site(s) on platelet glycoprotein IIb.IIIa complex inhibits receptor function. J. Biol. Chem. 265: 11766-11772. |
16 | Singh, S. M. and A. K. Panda. 2005. Solubilization and refolding of bacterial inclusion body proteins. J. Biosci. Bioeng. 99: 303-310. DOI ScienceOn |
17 | Wu, T. S., Y. Y. Chan, M. J. Liou, F. W. Lin, L. S. Shi, and K. T. Chen. 1998. Platelet aggregation inhibitor from Murraya euchrestifolia. Phytother. Res. 12: S80-S82. DOI ScienceOn |
18 | Lee, C., W. J. Sun, B. W. Burgess, B. H. Junker, J. Reddy, B. C. Buckland, and R. L. Greasham. 1997. Process optimization for large-scale production of TGF--PE40 in recombinant Escherichia coli: Effect of medium composition and induction timing on protein expression. J. Ind. Microbiol. Biotechnol. 18: 260-266. DOI ScienceOn |
19 | Ma, L. Y. and P. G. Xiao. 1998. Effect of Panax notoginseng saponins on platelet aggregation in rats with middle cerebral artery occlusion or in vitro and on lipid fluidity platelet membrane. Phytother. Res. 12: 138-140. DOI ScienceOn |
20 | Min, C. K., J. W. Lee, K. H. Chung, and H. W. Park. 2010. Control of specific rate to enhance the production of a novel disintegrin, saxatilin, in recombinant Pichia pastoris. J. Biosci. Bioeng. 110: 314-319. DOI ScienceOn |
21 | Yee, L. and H. W. Blanch. 1992. Recombinant protein expression in high cell density fed-batch cultures of Escherichia coli. Nat. Biotechnol. 10: 1550-1556. DOI ScienceOn |
22 | Park, Y. C., C. S. Kim, C. I. Kim, K. H. Choi, and J. H. Seo. 1997. Fed-batch fermentations of recombinant Escherichia coli to produce Bacillus macerans CGTase. J. Microbiol. Biotechnol. 7: 323-328. |
23 | Passarinha, L. A., M. J. Bonifacio, and J. A. Queiroz. 2009. Application of a fed-batch bioprocess for the heterologous production of hSCOMT in Escherichia coli. J. Microbiol. Biotechnol. 19: 972-981. DOI |
24 | Quintas-Granados, L. I., E. Orozco, L. G. Brieba, R. Arroyo, and J. Ortega-Lopez. 2009. Purification, refolding and autoactiviation of the recombinant cysteine proteinase EhCP112 from Entamoeba histolytica. Protein Expr. Purif. 63: 26-32. DOI ScienceOn |